1. Hua, Zhi-Dan, Liu, Xian-Bing, Sheng, Jian-Hui, Cai, Xiu-Qin, Han, Zhi-Qiang. . UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma. In Applied immunohistochemistry & molecular morphology : AIMM, 29, 585-591. doi:10.1097/PAI.0000000000000928. https://pubmed.ncbi.nlm.nih.gov/33734107/
2. Chen, Yougan, Sun, Fanghao, Zhang, Liansheng, Zhou, Jian, Hou, Jianquan. 2021. miR-499a inhibits the proliferation and apoptosis of prostate cancer via targeting UBE2V2. In World journal of surgical oncology, 19, 250. doi:10.1186/s12957-021-02371-7. https://pubmed.ncbi.nlm.nih.gov/34429120/
3. Chang, Yiming, Huang, Zhiyuan, Quan, Hong, Yuan, Jian, Wu, Chenming. 2023. Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer. In Frontiers in oncology, 12, 1085632. doi:10.3389/fonc.2022.1085632. https://pubmed.ncbi.nlm.nih.gov/36713553/
4. Wang, Hanyu, Peng, Chong, Hu, Guangbing, Hu, Yong, Pi, Honglin. 2024. Integrated Single-cell RNA-seq and Bulk RNA-seq Identify Diagnostic Biomarkers for Postmenopausal Osteoporosis. In Current medicinal chemistry, , . doi:10.2174/0109298673343344240930054414. https://pubmed.ncbi.nlm.nih.gov/39364870/